According to previous researches, TGR5 has been reported to have a significant impact on the progression of tumors and the development of metabolic disorders such as diabetes and obesity (Jin et al., 2024; Lun et al., 2024; Zhao et al., 2022; Bhimanwar and Mittal, 2022). This evidence concerns the gene GPBAR1 and metabolic disease.